Clinical outcomes after 44 years: do the legacy effects persits?

The long-term health benefits resulting from intensive (or tight) blood glucose management in diabetes care, the so-called legacy effect, are reflected in this MEDtalk. Let Professor Rury Holman present the 44-year UK Prospective Diabetes Study (UKPDS) follow-up results, which were also presented at the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden.